India Approves Tirzepatide-Based Weight Loss Drugs, Mounjaro and Zepbound
India’s apex drug regulator, the Central Drug Standard Control Organisation (CDSCO) has approved Eli Lilly’s tirzepatide, which is an active ingredient in Mounjaro and Zepbound. Tirzepatide ...
Times Now
2 hours ago